156,108 Cognex Corporation $CGNX Shares Bought by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA boosted its stake in shares of Cognex Corporation (NASDAQ:CGNX) by 2.7% in the 3rd quarter, Holdings Channel.com reports. The firm owned 5,985,986 shares of the scientific and technical instruments company’s stock after buying an additional 156,108 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Cognex were worth $363,002,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in the company. Parallel Advisors LLC raised its stake in shares of Cognex by 27.7% in the third quarter. Parallel Advisors LLC now owns 2,728 shares of the scientific and technical instruments company’s stock valued at $165,000 after purchasing an additional 591 shares in the last quarter. CenterBook Partners LP bought a new position in shares of Cognex in the third quarter valued at approximately $207,000. Kestra Advisory Services LLC increased its holdings in Cognex by 6.4% during the 3rd quarter. Kestra Advisory Services LLC now owns 3,502 shares of the scientific and technical instruments company’s stock valued at $212,000 after purchasing an additional 211 shares in the last quarter. Conestoga Capital Advisors LLC acquired a new stake in Cognex during the 3rd quarter valued at $10,860,000. Finally, Chicago Partners Investment Group LLC increased its holdings in Cognex by 12.4% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 18,857 shares of the scientific and technical instruments company’s stock valued at $1,048,000 after purchasing an additional 2,078 shares in the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CGNX. Zacks Research lowered Cognex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. Stephens decreased their price target on shares of Cognex from $85.00 to $70.00 and set an “overweight” rating on the stock in a research note on Friday. Barclays lifted their price objective on Cognex from $80.00 to $85.00 and gave the stock an “overweight” rating in a research report on Monday, October 12th. DA Davidson reiterated a “neutral” rating and set a $65.00 target price on shares of Cognex in a research report on Wednesday, September 23rd. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and issued a $91.00 price target on shares of Cognex in a research note on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $72.93.

Key Stories Impacting Cognex

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Cognex reported record Q3 results, with earnings of $0.53 per share beating estimates and revenue growing year over year. Management raised its 2026 revenue outlook to $1.14 billion–$1.16 billion and cited margin expansion and stronger logistics demand. Q3 earnings call outlook and margin expansion
• Positive Sentiment: The planned RealSense acquisition could add growth opportunities, while management is targeting further margin expansion. Cognex reports record third-quarter results and RealSense acquisition
• Positive Sentiment: The company raised its quarterly dividend by 5.9% to $0.09 per share, a modest signal of confidence in cash generation.
• Negative Sentiment: Several firms cut their price targets: Stephens lowered its target to $70, KeyCorp to $65, Needham to $70, and Truist to $57. The cuts may temper enthusiasm despite the improved outlook; ratings remain mostly overweight or buy, while Truist is at hold. Stephens price-target change

Cognex Trading Up 0.6%

Shares of CGNX opened at $47.78 on Friday. The firm has a fifty day simple moving average of $59.06 and a 200 day simple moving average of $58.04. Cognex Corporation has a 12 month low of $34.60 and a 12 month high of $72.88. The stock has a market capitalization of $8.04 billion, a price-to-earnings ratio of 33.41 and a beta of 1.49.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings data on Wednesday, November 4th. The scientific and technical instruments company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.01. The company had revenue of $313.39 million during the quarter, compared to analysts’ expectations of $313.62 million. Cognex had a return on equity of 15.75% and a net margin of 21.50%. Cognex’s revenue for the quarter was up 13.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.33 EPS. As a group, research analysts predict that Cognex Corporation will post 1.70 earnings per share for the current fiscal year.

Cognex Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 3rd. Stockholders of record on Thursday, November 19th will be given a $0.09 dividend. This is a boost from Cognex’s previous quarterly dividend of $0.0850. The ex-dividend date of this dividend is Thursday, November 19th. This represents a $0.36 dividend on an annualized basis and a dividend yield of 0.8%. Cognex’s payout ratio is 23.78%.

Cognex Company Profile